NovoCure Limited (NVCR) FY2026 YTD Q2 Statement of Cash Flows

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
NovoCure Limited cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Exercise of options → financing reconciliation: $2,845,000.00Proceeds from issuance of shares, net → financing reconciliation: $2,093,000.00financing reconciliation → Net cash from financing activities: $4,382,000.00financing reconciliation → Tax payments related to net settlements on equity awards: $556,000.00Proceeds from maturity of short-term investments → investing reconciliation: $205,000,000.00investing reconciliation → Net cash from investing activities: $1,369,000.00investing reconciliation → Purchase of short-term investments: $191,563,000.00investing reconciliation → Purchase of property, equipment and field equipment: $12,068,000.00Net cash used in operating activities → operating reconciliation: $5,385,000.00Share-based compensation → operating reconciliation: $80,021,000.00Depreciation and amortization → operating reconciliation: $8,431,000.00Decrease (increase) in other long-term assets → operating reconciliation: $4,949,000.00Asset write-downs and impairment of field equipment → operating reconciliation: $1,450,000.00Decrease (increase) in accounts receivables and prepaid expenses → operating reconciliation: $1,252,000.00Foreign currency remeasurement loss (gain) → operating reconciliation: $494,000.00operating reconciliation → Net income (loss): $86,796,000.00operating reconciliation → Increase (decrease) in other long-term liabilities: $5,626,000.00operating reconciliation → Amortization of discount (premium): $5,210,000.00operating reconciliation → Increase (decrease) in accounts payables and accrued expenses: $2,323,000.00operating reconciliation → Decrease (increase) in inventories: $1,912,000.00operating reconciliation → Accrued Interest: $115,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $103,390,000.00Net cash from financing activities → Cash sources and uses: $4,382,000.00Net cash from investing activities → Cash sources and uses: $1,369,000.00Cash sources and uses → Exchange-rate effect: $138,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $103,618,000.00Cash sources and uses → Net cash used in operating activities: $5,385,000.00Increase (decrease) in other long-term liabilities: -$5,626,000.00Other noncurrent liabilities−$5.63 MDecrease (increase) in other long-term assets: $4,949,000.00Other noncurrent assets+$4.95 MDepreciation and amortization: $8,431,000.00Depreciation & amortization+$8.43 MAsset write-downs and impairment of field equipment: $1,450,000.00Asset impairments+$1.45 MIncrease (decrease) in accounts payables and accrued expenses: -$2,323,000.00Payables & accrued liabilities−$2.32 MDecrease (increase) in inventories: -$1,912,000.00Inventories−$1.91 MAmortization of discount (premium): -$5,210,000.00Discount & premium amortization−$5.21 MAccrued Interest: -$115,000.00Accrued & other liabilities−$115.00 KNet income (loss): -$86,796,000.00Net income (loss)−$86.80 MForeign currency remeasurement loss (gain): $494,000.00FX transaction gain & loss+$494.00 KShare-based compensation: $80,021,000.00Stock-based compensation+$80.02 MDecrease (increase) in accounts receivables and prepaid expenses: $1,252,000.00Receivables & prepaid expenses+$1.25 MNet cash used in operating activities: -$5,385,000.00. Cash required to fund net payments.Operating cash−$5.39 Moperating reconciliation: $101,982,000.00Exercise of options: $2,845,000.00Stock option exercises+$2.85 MProceeds from senior secured credit facility, net: $0.00Proceeds from issuance of shares, net: $2,093,000.00Common stock issued+$2.09 MRepayment and redemption of long-term debt: $0.00Tax payments related to net settlements on equity awards: -$556,000.00Stock-award tax withholding−$556.00 KNet cash from financing activities: $4,382,000.00Financing cash+$4.38 Mfinancing reconciliation: $4,938,000.00Purchase of property, equipment and field equipment: -$12,068,000.00PP&E purchases−$12.07 MProceeds from maturity of short-term investments: $205,000,000.00HTM securities maturities+$205.00 MPurchase of short-term investments: -$191,563,000.00HTM securities purchases−$191.56 MNet cash from investing activities: $1,369,000.00Investing cash+$1.37 Minvesting reconciliation: $205,000,000.00Cash sources and uses: $109,141,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $103,390,000.00Beginning cash$103.39 MEnding cash: Cash, cash equivalents, and restricted cash: $103,618,000.00Ending cash$103.62 MExchange-rate effect: -$138,000.00FX effect−$138.00 KCASH RECONCILIATIONFinancingflowsInvestingflowsOperatingflowsNet loss −$86.80M + net operating adjustments $81.41M = operating cash −$5.39MFree cash flow−$17.45 MOperating cash − cash spent on PP&ECash flow / Net incomeNot meaningfulOperating cash flow ÷ net incomeNet cash change+$228.00 KEnding cash − beginning cash
Chart details

NovoCure Limited cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
103,390,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
negative 5,385,000 US dollars. Net cash used.
Net income (loss)
negative 86,796,000 US dollars
Increase (decrease) in other long-term liabilities
negative 5,626,000 US dollars
Decrease (increase) in other long-term assets
4,949,000 US dollars
Depreciation and amortization
8,431,000 US dollars
Asset write-downs and impairment of field equipment
1,450,000 US dollars
Increase (decrease) in accounts payables and accrued expenses
negative 2,323,000 US dollars
Decrease (increase) in inventories
negative 1,912,000 US dollars
Amortization of discount (premium)
negative 5,210,000 US dollars
Accrued Interest
negative 115,000 US dollars
Foreign currency remeasurement loss (gain)
494,000 US dollars
Share-based compensation
80,021,000 US dollars
Decrease (increase) in accounts receivables and prepaid expenses
1,252,000 US dollars
Investing activities
1,369,000 US dollars. Net cash provided.
Purchase of property, equipment and field equipment
negative 12,068,000 US dollars
Proceeds from maturity of short-term investments
205,000,000 US dollars
Purchase of short-term investments
negative 191,563,000 US dollars
Financing activities
4,382,000 US dollars. Net cash provided.
Exercise of options
2,845,000 US dollars
Proceeds from senior secured credit facility, net
0 US dollars
Proceeds from issuance of shares, net
2,093,000 US dollars
Repayment and redemption of long-term debt
0 US dollars
Tax payments related to net settlements on equity awards
negative 556,000 US dollars
Operating adjustment reconciliation
101,982,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
4,938,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
205,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 138,000 US dollars
Ending cash on Jun 30, 2026
103,618,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
109,141,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
228,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
Operating cash flow
negative 5,385,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
12,068,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
negative 17,453,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net loss −$86.80M + net operating adjustments $81.41M = operating cash −$5.39M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 5,385,000 US dollars minus 12,068,000 US dollars equals negative 17,453,000 US dollars.
NovoCure Limited (NVCR) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!